@article{250df17d72bd47bab80a18a3350f4ba5,
title = "Crushed deferasirox film-coated tablets in pediatric patients with transfusional hemosiderosis: Results from a single-arm, interventional phase 4 study (MIMAS)",
author = "Yasser Wali and Tamer Hassan and Pimlak Charoenkwan and Sara Trompeter and Immacolata Tartaglione and Raffaella Origa and Gamberini, {Maria Rita} and Vip Viprakasit and Miguel Izquierdo and Socrates Opio and Tania Roy and Ali Taher",
note = "Funding Information: received research grants and honoraria from Takeda, Novo Nordisk, Pfizer, and Novartis. Shared in advisory boards for Takeda, Pfizer, and Novartis. reported consultancy for bluebird bio and honoraria from Celgene and Novartis; reported speakers' bureau fees from Novartis and membership of the advisory committee for bluebird bio and Novartis; are employees of Novartis; provided consultancy and received research funding from Novartis Pharmaceuticals, Bristol‐Myers Squibb, Imara, Vifor, IONIS Pharmaceuticals and provided consultancy to Agios. declared no conflicts of interest. Wali Y Tartaglione I Origa R Miguel I, Socrates O, and Tania R Taher A Hassan T, Charoenkwan P, Trompeter S, Gamberini MR, and Viprakasit V ",
year = "2022",
doi = "10.1002/ajh.26598",
language = "English",
journal = "American Journal of Hematology",
issn = "0361-8609",
publisher = "Wiley-Liss Inc.",
}